Literature DB >> 2417042

Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.

S Z Langer, N Duval, R Massingham.   

Abstract

The concept that neurotransmitters can modulate their own release through presynaptic inhibitory autoreceptors is well established. The presynaptic inhibitory autoreceptors involved in a negative feedback mechanism that modulates the release of norepinephrine are of the alpha 2-subtype. Stimulation of central alpha 2-adrenoceptors by drugs like clonidine, guanfacine, and guanabenz produces an antihypertensive and bradycardiac effect through a decrease in sympathetic tone. In vascular smooth muscle, the alpha 1-adrenoceptor subtype predominates and mediates vasoconstriction although alpha 2-adrenoceptors mediating vasoconstriction are also present in some vascular beds. Phenylephrine preferentially stimulates alpha 1-adrenoceptors and guanabenz preferentially stimulates alpha 2-adrenoceptors in vascular smooth muscle, whereas norepinephrine is an agonist at both alpha 1- and alpha 2-subtypes. The pressor response to phenylephrine was markedly reduced by prazosin. In contrast, the response to norepinephrine was relatively resistant to blockade, and that to guanabenz, totally resistant to blockade by prazosin. Inhibition of neuronal uptake by cocaine or desipramine and pretreatment of cats with 6-hydroxydopamine increased the effectiveness of prazosin in blocking the pressor responses to norepinephrine, but not to guanabenz or phenylephrine. These results support the proposal that postsynaptic alpha 1-adrenoceptors are preferentially innervated (i.e., within the neuroeffector junction), while the postsynaptic alpha 2-adrenoceptors are in extrasynaptic locations. The subclassification of alpha-adrenoceptors into alpha 1- and alpha 2-subtypes opens the possibility of designing selective drugs to act as agonists or antagonists on these receptor subtypes. These compounds have useful therapeutic applications, and in the case of selective alpha 2-adrenoceptor antagonists, novel potential uses may exist, both at the level of the central nervous system and in the periphery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417042

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  11 in total

1.  Inhibition of adrenomedullary catecholamine release by propranolol isomers and clonidine involving mechanisms unrelated to adrenoceptors.

Authors:  A Orts; C Orellana; T Cantó; V Ceña; C González-García; A G García
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Sedative and analgesic effects of medetomidine in beagle dogs infected and uninfected with heartworm.

Authors:  C S Venugopalan; E P Holmes; M P Crawford; M J Kearney; V Fucci
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

3.  Influence of neuronal uptake on the contribution of smooth muscle alpha 2-adrenoceptors to vasoconstrictor responses to noradrenaline in SHR and WKY isolated tail arteries.

Authors:  I C Medgett; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

Review 4.  I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.

Authors:  B N Prichard; B R Graham
Journal:  Drugs Aging       Date:  2000-08       Impact factor: 3.923

5.  Pharmacokinetic-pharmacodynamic modeling of the effects of clonidine on pain threshold, blood pressure, and salivary flow.

Authors:  H C Porchet; P Piletta; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Adrenergic receptors and the regulation of vascular resistance in bullfrog tadpoles (Rana catesbeiana).

Authors:  P B Kimmel
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

7.  Postjunctional alpha 2-adrenoceptors mediate venoconstriction in the hindquarters circulation of anaesthetized cats.

Authors:  G A Bentley; R E Widdop
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

8.  Brain region and activity-dependent properties of M for calibrated fMRI.

Authors:  Christina Y Shu; Peter Herman; Daniel Coman; Basavaraju G Sanganahalli; Helen Wang; Christoph Juchem; Douglas L Rothman; Robin A de Graaf; Fahmeed Hyder
Journal:  Neuroimage       Date:  2015-10-31       Impact factor: 6.556

9.  Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743.

Authors:  D J Pettibone; B V Clineschmidt; V J Lotti; J J Baldwin; J R Huff; W C Randall; J Vacca; S D Young
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

10.  Contributions of alpha 1-adrenoceptors, alpha 2-adrenoceptors and P2x-purinoceptors to neurotransmission in several rabbit isolated blood vessels: role of neuronal uptake and autofeedback.

Authors:  A MacDonald; C J Daly; J M Bulloch; J C McGrath
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.